Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Pear Therapeutics logo

Pear Therapeutics

Recent Finacing

Equity

Recent Raise

$50M

Pear Therapeutics develops FDA‑authorized prescription digital therapeutics—reSET, reSET‑O, Somryst—and an end‑to‑end platform combining randomized clinical validation, digital biomarkers, machine‑learning, sensors, real‑world data, and telemedicine.

Founded 2013
Massachusetts, United States
101-250
Publicly Traded
peartherapeutics.com

Highlights

Focus Areas

Biotechnology
mHealth
Pharmaceutical
Software
Therapeutics

Recent Investors

5AM Ventures logo
JAZZ Venture Partners logo
Arboretum Ventures logo
Temasek logo
Novartis logo
EDBI logo
Bridge Builders Collaborative logo
Shanda Group logo
F
SoftBank Investment Advisers logo
QUAD Investment Management logo
C

Financials

$334M

Total Raised

8

Funding rounds

18

Investors


Team

Upgrade to view the team

See the team members at Pear Therapeutics.